Currently enrolling a Phase 2 trial to evaluate the role of complement factor B protein in age-related macular degeneration (AMD)
SPONSORED BY IONIS PHARMACEUTICALS
Advertisement
Articles by SPONSORED BY IONIS PHARMACEUTICALS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
DSLT for glaucoma and ocular hypertension: Real-world outcomes in 218 eyes
2
First patient dosed in phase 3 pivotal cohort of LIGHTHOUSE trial evaluating ATSN-201 for X-linked retinoschisis
3
ARPA-H funds tear-duct biosensor system for dry eye, systemic disease
4
Memento Medicines launches with $93 million Series A to advance Tie2-activating bispecific for retinal disease
5